Medical Research

US Measles Surge Challenges National Elimination Status
Clinical & Pharma US Measles Surge Challenges National Elimination Status

Determining the Scale of Resurgence Through Genomic Surveillance A sophisticated network of genetic detectives is currently racing to determine if the United States has permanently lost its hard-won status as a nation free from endemic measles transmission. The sudden escalation of measles cases

UAMS Launches Arkansas’ First Preventive Medicine Residency
Clinical & Pharma UAMS Launches Arkansas’ First Preventive Medicine Residency

While modern medicine excels at treating acute conditions in controlled clinical settings, Arkansas has long struggled with systemic health disparities that traditional bedside care alone cannot resolve. The recent accreditation of a specialized residency program at the University of Arkansas for

How Is Rajasthan Pioneering Universal Mental Health Care?
Clinical & Pharma How Is Rajasthan Pioneering Universal Mental Health Care?

The landscape of public health in Northern India is undergoing a profound transformation as the Rajasthan government implements a decentralized strategy to ensure that mental health services are no longer a luxury reserved for those living in major urban centers. Under the comprehensive Raj-Mamta

Is Pulmonary Denervation the Next Big Medtech Frontier?
Tech & Innovation Is Pulmonary Denervation the Next Big Medtech Frontier?

The Dawn of a New Therapeutic Category in Cardiovascular Medicine The recent infusion of capital into cardiovascular neuromodulation has redefined the boundaries of interventional medicine, positioning pulmonary artery denervation as a cornerstone of next-generation patient care. This shift

How Will New Policy Fast-Track Psychedelic Drug Approval?
Clinical & Pharma How Will New Policy Fast-Track Psychedelic Drug Approval?

The historical barrier separating clandestine laboratory research from mainstream clinical application has finally collapsed under the weight of a monumental federal mandate. For decades, the federal government maintained a rigid wall between drug enforcement and medical exploration, often

Can AI Solve the High Failure Rate in Drug Development?
Tech & Innovation Can AI Solve the High Failure Rate in Drug Development?

The pharmaceutical industry currently navigates a landscape where approximately ninety percent of all therapeutic candidates that enter clinical trials ultimately fail to reach the market, creating a massive financial and scientific bottleneck. This high rate of attrition frequently originates

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later